pirfenidone has been researched along with Aging in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glassberg, MK | 1 |
| Hewitt, RJ; Maher, TM | 1 |
| Abe, M; Hirasawa, Y; Sakayori, M; Suzuki, K; Tatsumi, K; Terada, J; Tsushima, K; Yoshioka, K | 1 |
| Locy, ML; Luckhardt, TR; Rangarajan, S; Thannickal, VJ | 1 |
| Corte, TJ; Jo, HE; Moodley, Y; Randhawa, S | 1 |
3 review(s) available for pirfenidone and Aging
| Article | Year |
|---|---|
Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape.
Topics: Age Distribution; Aging; Antineoplastic Agents; Chronic Disease; Comorbidity; Disease Progression; Health Expenditures; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Patient Education as Topic; Practice Guidelines as Topic; Pyridones; Sex Distribution | 2019 |
Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options.
Topics: Aging; Drug Development; Extracellular Matrix; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Pyridones; Randomized Controlled Trials as Topic | 2019 |
Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?
Topics: Aging; Clinical Trials, Phase II as Topic; Drug Approval; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Molecular Targeted Therapy; Pyridones | 2016 |
2 other study(ies) available for pirfenidone and Aging
| Article | Year |
|---|---|
Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Aging; Anti-Inflammatory Agents, Non-Steroidal; Drug Tolerance; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Pyridones; Retrospective Studies; Treatment Outcome | 2019 |
Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.
Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Agents; Biopsy; Comorbidity; Disease Management; Disease Progression; Female; Humans; Idiopathic Pulmonary Fibrosis; Incidence; Indoles; Male; Pyridones; Tomography, X-Ray Computed | 2016 |